TSCAN THERAPEUTICS INC's ticker is and the CUSIP is 89854M101. A total of 33 filers reported holding TSCAN THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 1.3%.
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| DC Funds, LP | 630,000 | $1,612,800 | 33.20% |
| Lynx1 Capital Management LP | 5,224,600 | $13,374,976 | 8.85% |
| EcoR1 Capital, LLC | 5,000,000 | $12,800,000 | 0.43% |
| Deer Management Co. LLC | 1,245,505 | $3,188,493 | 0.39% |
| Simplify Asset Management Inc. | 1,046,916 | $2,680,105 | 0.31% |
| BVF INC/IL | 2,989,474 | $7,653,053 | 0.21% |
| Alphabet Inc. | 1,077,080 | $2,757,324 | 0.18% |
| DC Investments Management, LLC | 35,563 | $91,041 | 0.11% |
| Baker Brothers Advisors | 2,784,792 | $7,129,068 | 0.04% |
| Privium Fund Management (UK) Ltd | 15,825 | $41,462 | 0.03% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 4,000,000 | $10,240,000 | 0.02% |
| Aries Wealth Management | 10,000 | $35,300 | 0.01% |
| NewEdge Wealth, LLC | 91,463 | $234,145 | 0.01% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 88,300 | $226,048 | 0.01% |
| Pale Fire Capital SE | 16,575 | $42,432 | 0.00% |
| LETKO, BROSSEAU & ASSOCIATES INC | 32,400 | $82,944 | 0.00% |
| Waldron Private Wealth LLC | 10,000 | $25 | 0.00% |
| BANK OF AMERICA CORP /DE/ | 200 | $512 | 0.00% |
| STIFEL FINANCIAL CORP | 116,900 | $299,264 | 0.00% |
| WELLS FARGO & COMPANY/MN | 286 | $732 | 0.00% |
This page lists TSCAN THERAPEUTICS INC's shareholders in Q3 2023. To view TSCAN THERAPEUTICS INC's shareholder history, click here.